School of Medicine, Institute of Biomedicine, University of Eastern Finland, FIN-70210 Kuopio, Finland.
J Steroid Biochem Mol Biol. 2013 Jul;136:62-7. doi: 10.1016/j.jsbmb.2012.11.011. Epub 2012 Dec 7.
The basic helix-loop-helix protein BHLHE40 functions as a transcriptional repressor and is involved in the control of cellular growth, development and circadian rhythms. By the use of genome-wide data on vitamin D receptor (VDR) location, open chromatin and histone modification backed-up by gene-specific mRNA expression studies we show that the human BHLHE40 gene is dynamically up-regulated by the VDR ligand 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) and down-regulated by the histone deactylase inhibitor trichostatin A. The VDR binding site is located 1.7kb upstream of the transcription start site of the BHLHE40 gene and the chromatin at this genomic site is significantly opened by treatment with 1α,25(OH)2D3. The stair case style fluctuations in the BHLHE40 mRNA accumulation relate to the short half-life of the gene's mRNA of 0.9h. The identification of the widely expressed BHLHE40 gene as a primary VDR target may explain secondary effects of 1α,25(OH)2D3 on BHLHE40 responding genes. This article is part of a Special Issue entitled 'Vitamin D Workshop'.
碱性螺旋-环-螺旋蛋白 BHLHE40 作为转录抑制剂发挥作用,参与细胞生长、发育和昼夜节律的控制。通过使用基因组范围内的维生素 D 受体 (VDR) 位置、开放染色质和组蛋白修饰的数据,并辅以基因特异性 mRNA 表达研究,我们表明人 BHLHE40 基因可被 VDR 配体 1α,25-二羟维生素 D3(1α,25(OH)2D3) 动态上调,并被组蛋白脱乙酰酶抑制剂曲古抑菌素 A 下调。VDR 结合位点位于 BHLHE40 基因转录起始点上游 1.7kb 处,用 1α,25(OH)2D3 处理后,该基因组位点的染色质显著开放。BHLHE40 mRNA 积累的阶梯式波动与该基因 mRNA 的半衰期为 0.9h 有关。广泛表达的 BHLHE40 基因作为 VDR 的主要靶标之一,可能解释了 1α,25(OH)2D3 对 BHLHE40 应答基因的次级作用。本文是主题为“维生素 D 研讨会”的特刊的一部分。